Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache
- PMID: 30286616
- DOI: 10.1177/0333102418804157
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache
Abstract
Background: Loss of conditioned pain modulation/diffuse noxious inhibitory controls has been demonstrated in patients with migraine and medication overuse headache. We hypothesized that exposure to acute migraine medications may lead to dysregulation of central pain modulatory circuits that could be revealed by evaluating diffuse noxious inhibitory controls and that prior noxious stimulus is required for a loss of the diffuse noxious inhibitory control response in rats exposed to these medications.
Methods: Rats were "primed" by continuous infusion of morphine or one of two doses of sumatriptan. Diffuse noxious inhibitory control was evaluated at the end of drug-priming (day 7) and again after sensory thresholds returned to baseline (day 21). The Randall-Selitto hindpaw pressure test was used as the test stimulus and forepaw capsaicin injection served as the conditioning stimulus.
Results: Morphine-primed rats showed opioid-induced hyperalgesia accompanied by a loss of diffuse noxious inhibitory controls on day 7. Sumatriptan-primed rats did not develop hyperalgesia or loss of diffuse noxious inhibitory controls on day 7. Morphine-primed and high-dose sumatriptan-primed rats only had a loss of diffuse noxious inhibitory control on day 21 if they received a capsaicin injection on day 7.
Conclusions: Prolonged exposure to migraine treatments followed by an acute nociceptive stimulation caused long-lasting alterations in descending pain modulation, shown by a loss of diffuse noxious inhibitory controls. Morphine was more detrimental than sumatriptan, consistent with clinical observations of higher medication overuse headache risk with opioids. These data suggest a mechanism of medication overuse headache by which migraine medications combined with repeated episodes of pain may amplify the consequences of nociceptor activation and increase the probability of future migraine attacks as well as risk of medication overuse headache.
Keywords: Conditioned pain modulation; diffuse noxious inhibitory controls; hyperalgesic priming; morphine; opioid induced hyperalgesia; sumatriptan.
Similar articles
-
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.Cephalalgia. 2020 Aug;40(9):892-902. doi: 10.1177/0333102420938652. Epub 2020 Jul 2. Cephalalgia. 2020. PMID: 32615788 Free PMC article.
-
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.Cephalalgia. 2021 May;41(6):749-759. doi: 10.1177/0333102420981688. Epub 2021 Feb 20. Cephalalgia. 2021. PMID: 33615840
-
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.Cephalalgia. 2021 Mar;41(3):305-317. doi: 10.1177/0333102420959794. Epub 2020 Sep 26. Cephalalgia. 2021. PMID: 32985222 Free PMC article.
-
Update on medication-overuse headache.Curr Pain Headache Rep. 2011 Feb;15(1):79-83. doi: 10.1007/s11916-010-0155-1. Curr Pain Headache Rep. 2011. PMID: 21058047 Free PMC article. Review.
-
Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache.Curr Opin Neurol. 2011 Jun;24(3):193-6. doi: 10.1097/WCO.0b013e328346af25. Curr Opin Neurol. 2011. PMID: 21467931 Free PMC article. Review.
Cited by
-
Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.Pain. 2020 Mar;161(3):609-618. doi: 10.1097/j.pain.0000000000001748. Pain. 2020. PMID: 31725062 Free PMC article.
-
Diffuse Noxious Inhibitory Controls in Chronic Pain States: Insights from Pre-Clinical Studies.Int J Mol Sci. 2025 Jan 5;26(1):402. doi: 10.3390/ijms26010402. Int J Mol Sci. 2025. PMID: 39796255 Free PMC article. Review.
-
Neurobiology of migraine progression.Neurobiol Pain. 2022 Jun 9;12:100094. doi: 10.1016/j.ynpai.2022.100094. eCollection 2022 Aug-Dec. Neurobiol Pain. 2022. PMID: 35720639 Free PMC article. Review.
-
A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.Int J Mol Sci. 2020 Jun 5;21(11):4049. doi: 10.3390/ijms21114049. Int J Mol Sci. 2020. PMID: 32516986 Free PMC article.
-
Developments in Understanding Diffuse Noxious Inhibitory Controls: Pharmacological Evidence from Pre-Clinical Research.J Pain Res. 2021 Apr 20;14:1083-1095. doi: 10.2147/JPR.S258602. eCollection 2021. J Pain Res. 2021. PMID: 33907456 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical